MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comparison of gait pattern characteristics during Parkinson’s disease progression – Analysis of gait during the dual-task walking

S. Radovanovic, V. Markovic, I. Stankovic, S. Gluscevic, I. Petrovic, V. Kostic (Belgrade, Serbia)

Meeting: MDS Virtual Congress 2020

Abstract Number: 432

Keywords: Apathy, Depression, Gait disorders: Clinical features

Category: Parkinson's Disease: Cognitive functions

Objective: We investigated gait characteristics and contribution of clinical presentation and cognitive functioning to the gait characteristics in different Parkinson’s disease (PD) stages. Our aim was to elucidate relatively specific disease differences during disease progression in gait pattern. We compared clinical signs of PD stadiums and their correlation to gait characteristics.

Background: Gait alterations are observable phenomena in movement disorders patients. The impact of motor sign severity on gait performance and characteristics in PD has been well established. However, gait is not automated motor activity, even subtle cognitive disorders, most importantly in the domains of executive functions, are associated with a higher risk of falls and gait alterations in PD patients. Executive functioning is critical in complex gait situations, such as dual tasks performance while walking.

Method: PD patients (60 – 22F, 38M) performed demanding dual mental and motor tasks while walking on GAITRite electronic walkway carpet. Patients were chosen between three H&Y stage subgroups: H&Y 1, H&Y 2 and H&Y 3 – 20 patients in each group. Patients and 35 matched control subjects performed a basic walking task, a dual-motor task, a dual-mental task, and a combined motor and mental task while walking. Analyzed parameters were cycle time, stride length, swing time, double support time and variability of those four parameters.

Results: Results show significant impairment of temporal and spatial gait parameters in PD between stages of the disease. When PD patients were divided into subgroups, variability of gait was minor in subgroup H&Y 1, and more pronounced in later stages (H&Y 2), and further more in H&Y 3. Parameters become even more impaired during a simultaneous cognitive task. When the motor or combined tasks are performed, there is additional impairment of gait stability (significantly increased double support time).

Conclusion: It can be concluded that changes during disease progression point to gait and posture function disturbance. Further, particularly cognitive changes and behavioral symptoms and their changes during PD disease progression are correlated to gait function disturbances.

To cite this abstract in AMA style:

S. Radovanovic, V. Markovic, I. Stankovic, S. Gluscevic, I. Petrovic, V. Kostic. Comparison of gait pattern characteristics during Parkinson’s disease progression – Analysis of gait during the dual-task walking [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/comparison-of-gait-pattern-characteristics-during-parkinsons-disease-progression-analysis-of-gait-during-the-dual-task-walking/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/comparison-of-gait-pattern-characteristics-during-parkinsons-disease-progression-analysis-of-gait-during-the-dual-task-walking/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley